← Evidence map

ArticleHaematologica2010

Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.

Emanuela Messa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

62 papers cite itlatest 60 shown

2010
…
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 20534700